Login / Signup
Exosomal profiling should be used to monitor disease activity in MS patients: Commentary.
Martina Gabrielli
Claudia Verderio
Published in:
Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Keyphrases
</>
disease activity
rheumatoid arthritis
systemic lupus erythematosus
end stage renal disease
rheumatoid arthritis patients
newly diagnosed
ankylosing spondylitis
ejection fraction
chronic kidney disease
mass spectrometry
multiple sclerosis
peritoneal dialysis
prognostic factors
single cell
patient reported